Legend Biotech Overview
Valuation check: LEGN's PEG ratio is 34.53, above the Healthcare sector average of 2.89.
Get informed when a big investor buys or sells
+ Follow34.53
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Legend Biotech (LEGN) currently reports a PEG ratio of 34.53. That is above the Healthcare sector average of 2.89. Use the charts on this page to explore Legend Biotech's PEG ratio history and peer comparisons.
Legend Biotech's PEG ratio of 34.53 is higher than the Healthcare sector average of 2.89. That is roughly 1094.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Legend Biotech's market price to a fundamental measure such as earnings, sales, or book value. At 34.53, LEGN can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 34.53, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 2.89. From there, open related valuation or income-statement pages for Legend Biotech, and consider following LEGN for alerts when major investors trade the stock.
Legend Biotech is classified in the Healthcare sector. On PEG ratio, it currently shows 34.53 versus a sector average near 2.89. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LEGN with unrelated industries.
